Efficacy of High-Dose Blinatumomab in Richter’s Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A phase two study of high dose blinatumomab in Richter's syndrome
Leukemia 2022 Aug 08;[EPub Ahead of Print], PA Thompson, X Jiang, P Banerjee, R Basar, N Garg, K Chen, M Kaplan, V Nandivada, AKN Cortes, A Ferrajoli, MJ Keating, CB Peterson, M Andreeff, K Rezvani, WG WierdaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.